Table 2 Comparison of BP-treated and non-BP-treated patient groups
From: Administration of bisphosphonate for hypercalcemia associated with oral cancer
Characteristics | BP group (n = 9) | non-BP group (n = 7) | p value* |
|---|---|---|---|
| Â | median (min.~max.) | median (min.~max.) | Â |
Age | 50(24~73) | 76 (58~84) | 0.0050 |
WBC (x1000/m3) | 7.1 (6.1~16.4) | 8.4 (4.1~35.8) | 0.958 |
Hb (g/dl) | 10.3 (7.3~14.5) | 11.2 (9.2~14.4) | 0.397 |
Plt (x10000/m3) | 32.9 (152~742) | 27.8 (192~438) | 0.315 |
AST (IU/dl) | 17 (11~87) | 26 (13~106) | 0.290 |
ALT (IU/dl) | 14 (6~129) | 48 (9~267) | 0.050 |
LDH (IU/dl) | 173 (112~487) | 287 (137~408) | 0.596 |
ALP (IU/dl) | 269 (184~721) | 322 (171~867) | 0.427 |
Cre (mg/dl) | 0.8 (0.5~1.0) | 0.8 (0.3~0.9) | 0.871 |
CRP (mg/dl) | 3.3 (0.7~19) | 4.7 (1.4~13.8) | 0.186 |